Carbon ion re-irradiation for returning head and neck cancer
Part of Cancer, Ear, nose & throat clinical trials.
This trial tests a type of radiation called carbon-ion re-irradiation for people whose head and neck cancer has come back or grown again after earlier radiation. It may help control the cancer after certain surgeries, but it also requires specific safety conditions about timing, prior treatment areas, and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your head-and-neck cancer has come back or grown again after you previously had radiation
- You’ve had salvage (additional) surgery and there may still be visible or microscopic tumor afterward
- Your doctors think re-irradiation (giving radiation again) is an appropriate next step for your case
- You finished healing from your surgery before starting the trial
- You are at least 18 years old and can take part safely (Karnofsky score 60 or higher)
- You can share past radiation records and use reliable contraception if needed; you must be able to consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies carbon ion radiation (a specific type of high-energy radiation) for people with head and neck adenoid cystic carcinoma when surgery isn’t possible or was incomplete. It may help shrink or control the cancer while limiting side effects compared with other approaches.
This pilot study tests whether cooling treatment on the tumor area (cryotherapy) can control a repeat head/neck cancer that can’t be removed and has already been treated with radiation. It also checks safety, especially in areas that have received radiation before.
This trial tests a “salvage” treatment that combines targeted radiation (brachytherapy) with controlled body warming (hyperthermia) for head and neck cancer that has come back. It may help by better shrinking tumors while fitting the treatment to the tumor’s exact location.
This trial tests whether carbon ion radiation can safely treat rectal cancer that has come back in the pelvis after you already had radiation before. It may help shrink or control the tumor when other options are limited, but it requires careful timing and spacing from nearby organs.
This trial tests a combination of re-radiation and chemotherapy with the immunotherapy drug pembrolizumab for people whose head and neck cancer has come back after earlier treatment. It compares this approach to standard immunotherapy or chemo-immunotherapy, and may offer a new option for patients whose cancer has a specific marker (PD-L1).
This trial tests combining re-radiation (radiation therapy given a second time) with a drug called chidamide to treat head and neck cancer that has come back after previous radiation. The goal is to see if this combination can help patients whose cancer cannot be removed by surgery or who cannot have surgery.
Hear when a new Locally Advanced Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.